| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | fibroblast growth factor receptor activity | 2.70e-08 | 5 | 173 | 4 | GO:0005007 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 1.48e-06 | 65 | 173 | 7 | GO:0004714 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 9.07e-06 | 85 | 173 | 7 | GO:0019199 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 3.93e-05 | 145 | 173 | 8 | GO:0004713 | |
| GeneOntologyMolecularFunction | D-erythro-sphingosine kinase activity | 7.46e-05 | 2 | 173 | 2 | GO:0017050 | |
| GeneOntologyMolecularFunction | sphingosine kinase activity | 7.46e-05 | 2 | 173 | 2 | GO:0008481 | |
| GeneOntologyMolecularFunction | fibroblast growth factor binding | 8.17e-05 | 27 | 173 | 4 | GO:0017134 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | SPHK2 PDGFRB INSR MAP3K20 DGKG TEC ERN2 MAP3K12 NEK9 SPHK1 SIK2 FGFR1 FGFR3 MAP3K15 FGFR2 FGFR4 MERTK | 1.50e-04 | 709 | 173 | 17 | GO:0016773 |
| GeneOntologyMolecularFunction | kinase activity | SPHK2 PDGFRB INSR MAP3K20 DGKG TEC ERN2 MAP3K12 NEK9 SPHK1 SIK2 FGFR1 FGFR3 MAP3K15 FGFR2 FGFR4 MERTK | 3.58e-04 | 764 | 173 | 17 | GO:0016301 |
| GeneOntologyMolecularFunction | growth factor binding | 4.28e-04 | 156 | 173 | 7 | GO:0019838 | |
| GeneOntologyMolecularFunction | stalled ribosome sensor activity | 4.43e-04 | 4 | 173 | 2 | GO:0170011 | |
| GeneOntologyMolecularFunction | dATP binding | 7.34e-04 | 5 | 173 | 2 | GO:0032564 | |
| GeneOntologyMolecularFunction | histone H3K9me/H3K9me2 demethylase activity | 7.34e-04 | 5 | 173 | 2 | GO:0140683 | |
| GeneOntologyMolecularFunction | protein kinase activity | PDGFRB INSR MAP3K20 TEC ERN2 MAP3K12 NEK9 SIK2 FGFR1 FGFR3 MAP3K15 FGFR2 FGFR4 MERTK | 7.58e-04 | 600 | 173 | 14 | GO:0004672 |
| GeneOntologyMolecularFunction | protein-hormone receptor activity | 8.72e-04 | 22 | 173 | 3 | GO:0016500 | |
| GeneOntologyMolecularFunction | nuclease activity | 9.36e-04 | 231 | 173 | 8 | GO:0004518 | |
| GeneOntologyMolecularFunction | adenyl deoxyribonucleotide binding | 1.09e-03 | 6 | 173 | 2 | GO:0032558 | |
| GeneOntologyMolecularFunction | piRNA binding | 1.09e-03 | 6 | 173 | 2 | GO:0034584 | |
| GeneOntologyMolecularFunction | endonuclease activity | 1.20e-03 | 136 | 173 | 6 | GO:0004519 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.49e-03 | 193 | 173 | 7 | GO:0015276 | |
| GeneOntologyMolecularFunction | purine deoxyribonucleotide binding | 1.52e-03 | 7 | 173 | 2 | GO:0032554 | |
| GeneOntologyMolecularFunction | MAP kinase kinase kinase activity | 1.60e-03 | 27 | 173 | 3 | GO:0004709 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.68e-03 | 197 | 173 | 7 | GO:0022834 | |
| GeneOntologyMolecularFunction | sphingosine-1-phosphate receptor activity | 2.02e-03 | 8 | 173 | 2 | GO:0038036 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | INTU PDGFRB RPS3 VPS4B INSR MAP3K20 OOEP FSD1 PIWIL2 NLGN1 ARHGAP35 NEB MORC2 LMOD3 CORO1A KANK1 PTPRD TBC1D10A VILL PTPRS SPHK1 SORBS3 SMARCA2 SMARCC2 FGFR1 FGFR3 FGFR2 HTT | 7.04e-06 | 1342 | 173 | 28 | GO:0033043 |
| GeneOntologyBiologicalProcess | regulation of postsynaptic density assembly | 2.56e-05 | 21 | 173 | 4 | GO:0099151 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic specialization assembly | 6.19e-05 | 26 | 173 | 4 | GO:0099150 | |
| GeneOntologyBiologicalProcess | regulation of excitatory synapse assembly | 6.19e-05 | 26 | 173 | 4 | GO:1904889 | |
| GeneOntologyBiologicalProcess | fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development | 6.99e-05 | 2 | 173 | 2 | GO:0035607 | |
| GeneOntologyBiologicalProcess | positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure | 6.99e-05 | 2 | 173 | 2 | GO:0001988 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic density organization | 7.21e-05 | 27 | 173 | 4 | GO:1905874 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling by trans-synaptic complex | 9.11e-05 | 11 | 173 | 3 | GO:0099545 | |
| GeneOntologyBiologicalProcess | positive regulation of MAPK cascade | JCAD PDGFRB RPS3 INSR ERN2 MAP3K12 LEPR CHRNA7 SPHK1 SORBS3 FGFR1 FGFR3 FGFR2 FGFR4 CHRFAM7A | 9.79e-05 | 571 | 173 | 15 | GO:0043410 |
| GeneOntologyBiologicalProcess | postsynaptic density organization | 1.25e-04 | 58 | 173 | 5 | GO:0097106 | |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, dopaminergic | 1.56e-04 | 13 | 173 | 3 | GO:0032225 | |
| GeneOntologyBiologicalProcess | coronary vasculature morphogenesis | 1.82e-04 | 34 | 173 | 4 | GO:0060977 | |
| GeneOntologyBiologicalProcess | postsynaptic density assembly | 1.82e-04 | 34 | 173 | 4 | GO:0097107 | |
| GeneOntologyBiologicalProcess | positive regulation of phospholipase activity | 1.97e-04 | 14 | 173 | 3 | GO:0010518 | |
| GeneOntologyBiologicalProcess | fibroblast growth factor receptor apoptotic signaling pathway | 2.09e-04 | 3 | 173 | 2 | GO:1902178 | |
| GeneOntologyBiologicalProcess | ventricular zone neuroblast division | 2.09e-04 | 3 | 173 | 2 | GO:0021847 | |
| GeneOntologyBiologicalProcess | orbitofrontal cortex development | 2.09e-04 | 3 | 173 | 2 | GO:0021769 | |
| GeneOntologyBiologicalProcess | baroreceptor response to decreased systemic arterial blood pressure | 2.09e-04 | 3 | 173 | 2 | GO:0001982 | |
| GeneOntologyBiologicalProcess | male gamete generation | CFAP47 KDM3A METTL3 RAD18 SPATA31E1 NUP210L PIWIL1 PIWIL2 NME8 CADM1 ZNF35 SMARCA2 SPATA22 MERTK FIGNL1 HTT TDRP | 2.39e-04 | 762 | 173 | 17 | GO:0048232 |
| GeneOntologyBiologicalProcess | regulation of cytoplasmic translation | 2.54e-04 | 37 | 173 | 4 | GO:2000765 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle process | RAD18 PDGFRB VPS4B INSR MAP3K20 OOEP PIWIL2 SPHK1 FGFR1 CDC73 | 2.77e-04 | 307 | 173 | 10 | GO:0090068 |
| GeneOntologyBiologicalProcess | MAPK cascade | JCAD ITCH PDGFRB RPS3 INSR MAP3K20 GRIK2 ERN2 MAP3K12 LEPR CHRNA7 SPHK1 SORBS3 FGFR1 FGFR3 MAP3K15 FGFR2 FGFR4 CHRFAM7A | 3.12e-04 | 930 | 173 | 19 | GO:0000165 |
| GeneOntologyBiologicalProcess | postsynapse organization | UBE3B INSR NLGN1 CHRNA7 CADM1 PTPRD PTPRS FGFR1 CTNND2 CHRFAM7A | 3.23e-04 | 313 | 173 | 10 | GO:0099173 |
| GeneOntologyBiologicalProcess | postsynaptic specialization organization | 3.26e-04 | 71 | 173 | 5 | GO:0099084 | |
| GeneOntologyBiologicalProcess | generation of ovulation cycle rhythm | 4.15e-04 | 4 | 173 | 2 | GO:0060112 | |
| GeneOntologyBiologicalProcess | pachytene | 4.15e-04 | 4 | 173 | 2 | GO:0000239 | |
| GeneOntologyBiologicalProcess | GCN2-mediated signaling | 4.15e-04 | 4 | 173 | 2 | GO:0140469 | |
| GeneOntologyBiologicalProcess | alveolar secondary septum development | 4.15e-04 | 4 | 173 | 2 | GO:0061144 | |
| GeneOntologyBiologicalProcess | positive regulation of parathyroid hormone secretion | 4.15e-04 | 4 | 173 | 2 | GO:2000830 | |
| GeneOntologyBiologicalProcess | synaptic membrane adhesion | 4.17e-04 | 42 | 173 | 4 | GO:0099560 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear division | 4.21e-04 | 75 | 173 | 5 | GO:0051785 | |
| GeneOntologyBiologicalProcess | dendritic spine organization | 4.22e-04 | 115 | 173 | 6 | GO:0097061 | |
| GeneOntologyBiologicalProcess | vasculogenesis involved in coronary vascular morphogenesis | 4.31e-04 | 18 | 173 | 3 | GO:0060979 | |
| GeneOntologyBiologicalProcess | negative regulation of dendritic spine development | 4.31e-04 | 18 | 173 | 3 | GO:0061000 | |
| GeneOntologyBiologicalProcess | postsynaptic specialization assembly | 4.99e-04 | 44 | 173 | 4 | GO:0098698 | |
| GeneOntologyBiologicalProcess | regulation of MAPK cascade | JCAD ITCH PDGFRB RPS3 INSR GRIK2 ERN2 MAP3K12 LEPR CHRNA7 SPHK1 SORBS3 FGFR1 FGFR3 FGFR2 FGFR4 CHRFAM7A | 5.17e-04 | 815 | 173 | 17 | GO:0043408 |
| GeneOntologyBiologicalProcess | spermatogenesis | CFAP47 KDM3A METTL3 RAD18 SPATA31E1 NUP210L PIWIL1 PIWIL2 NME8 CADM1 ZNF35 SMARCA2 SPATA22 MERTK HTT TDRP | 5.46e-04 | 744 | 173 | 16 | GO:0007283 |
| GeneOntologyBiologicalProcess | organelle assembly | CFAP47 INTU PDGFRB MYO7A RPS3 VPS4B DNAH2 NLGN1 ARHGAP35 NEB CEP164 NME8 LMOD3 CORO1A PTPRD TBC1D10A PTPRS TNRC6A FGFR1 HTT MYBPC2 | 5.77e-04 | 1138 | 173 | 21 | GO:0070925 |
| GeneOntologyBiologicalProcess | excitatory synapse assembly | 5.93e-04 | 46 | 173 | 4 | GO:1904861 | |
| GeneOntologyBiologicalProcess | regulation of protein kinase C signaling | 5.95e-04 | 20 | 173 | 3 | GO:0090036 | |
| GeneOntologyBiologicalProcess | regulation of organelle assembly | 6.14e-04 | 280 | 173 | 9 | GO:1902115 | |
| GeneOntologyBiologicalProcess | regulation of nuclear division | 6.33e-04 | 172 | 173 | 7 | GO:0051783 | |
| GeneOntologyBiologicalProcess | regulation of meiotic cell cycle | 6.35e-04 | 82 | 173 | 5 | GO:0051445 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle | RAD18 PDGFRB VPS4B INSR MAP3K20 OOEP PIWIL2 SPHK1 FGFR1 FGFR2 CDC73 | 6.69e-04 | 407 | 173 | 11 | GO:0045787 |
| GeneOntologyBiologicalProcess | sensory processing | 6.88e-04 | 5 | 173 | 2 | GO:0050893 | |
| GeneOntologyBiologicalProcess | formaldehyde metabolic process | 6.88e-04 | 5 | 173 | 2 | GO:0046292 | |
| GeneOntologyBiologicalProcess | negative regulation of protein refolding | 6.88e-04 | 5 | 173 | 2 | GO:0061084 | |
| GeneOntologyBiologicalProcess | retrograde trans-synaptic signaling by trans-synaptic protein complex | 6.88e-04 | 5 | 173 | 2 | GO:0098942 | |
| GeneOntologyBiologicalProcess | regulation of parathyroid hormone secretion | 6.88e-04 | 5 | 173 | 2 | GO:2000828 | |
| GeneOntologyBiologicalProcess | protein autophosphorylation | 6.99e-04 | 228 | 173 | 8 | GO:0046777 | |
| GeneOntologyBiologicalProcess | neuron projection organization | 7.14e-04 | 127 | 173 | 6 | GO:0106027 | |
| GeneOntologyCellularComponent | receptor complex | TRAF1 PDGFRB INSR PKD2L1 GRIK2 NLGN1 ADGRV1 LEPR CHRNA7 IGHD FGFR1 FGFR3 FGFR2 FGFR4 MERTK CHRFAM7A | 2.98e-05 | 581 | 174 | 16 | GO:0043235 |
| GeneOntologyCellularComponent | presynaptic membrane | ANO2 GRIK2 DNAJC6 CHRNA7 CADM1 PTPRD OTOF PTPRS CNTNAP4 CHRFAM7A | 1.14e-04 | 277 | 174 | 10 | GO:0042734 |
| GeneOntologyCellularComponent | spine apparatus membrane | 2.06e-04 | 3 | 174 | 2 | GO:0098897 | |
| GeneOntologyCellularComponent | subcortical maternal complex | 4.09e-04 | 4 | 174 | 2 | GO:0106333 | |
| HumanPheno | Cloverleaf skull | 1.34e-06 | 8 | 62 | 4 | HP:0002676 | |
| HumanPheno | Abnormality of the distal phalanx of the hallux | 9.16e-06 | 12 | 62 | 4 | HP:0010053 | |
| HumanPheno | Short middle phalanx of toe | 1.69e-05 | 5 | 62 | 3 | HP:0003795 | |
| MousePheno | premature bone ossification | 1.62e-07 | 26 | 138 | 6 | MP:0003416 | |
| MousePheno | abnormal facial suture morphology | 3.74e-06 | 4 | 138 | 3 | MP:0030230 | |
| MousePheno | premature metopic suture closure | 3.74e-06 | 4 | 138 | 3 | MP:0030367 | |
| MousePheno | premature intramembranous bone ossification | 8.43e-06 | 14 | 138 | 4 | MP:0003418 | |
| MousePheno | premature cranial suture closure | 8.43e-06 | 14 | 138 | 4 | MP:0000081 | |
| MousePheno | premature craniofacial suture closure | 8.43e-06 | 14 | 138 | 4 | MP:0030435 | |
| MousePheno | abnormal cranial synchondrosis | 1.84e-05 | 6 | 138 | 3 | MP:0030443 | |
| MousePheno | midface hypoplasia | 1.96e-05 | 17 | 138 | 4 | MP:0012085 | |
| MousePheno | face hypoplasia | 3.14e-05 | 19 | 138 | 4 | MP:0030065 | |
| MousePheno | abnormal cranial cartilage development | 7.57e-05 | 9 | 138 | 3 | MP:0030467 | |
| MousePheno | abnormal maxillary-premaxillary suture morphology | 9.68e-05 | 2 | 138 | 2 | MP:0014051 | |
| MousePheno | airway basal cell hyperplasia | 9.68e-05 | 2 | 138 | 2 | MP:0011115 | |
| MousePheno | abnormal airway basal cell differentiation | 9.68e-05 | 2 | 138 | 2 | MP:0011114 | |
| MousePheno | abnormal airway basal cell morphology | 9.68e-05 | 2 | 138 | 2 | MP:0011113 | |
| MousePheno | absent cochlear hair bundle ankle links | 9.68e-05 | 2 | 138 | 2 | MP:0004582 | |
| MousePheno | abnormal cochlear hair bundle ankle links morphology | 9.68e-05 | 2 | 138 | 2 | MP:0004581 | |
| MousePheno | premature facial suture closure | 9.68e-05 | 2 | 138 | 2 | MP:0030390 | |
| MousePheno | abnormal midface morphology | 1.55e-04 | 28 | 138 | 4 | MP:0030095 | |
| MousePheno | ocular hypertelorism | 1.78e-04 | 29 | 138 | 4 | MP:0001300 | |
| MousePheno | abnormal stapes morphology | 2.33e-04 | 31 | 138 | 4 | MP:0005107 | |
| MousePheno | premature cranial synchondrosis closure | 2.88e-04 | 3 | 138 | 2 | MP:0030444 | |
| Domain | Ig_I-set | PDGFRB FSTL4 IGSF22 CADM1 HMCN2 PTPRD PTPRS PXDNL FGFR1 FGFR3 FGFR2 FGFR4 MERTK MYBPC2 | 2.75e-09 | 190 | 173 | 14 | IPR013098 |
| Domain | I-set | PDGFRB FSTL4 IGSF22 CADM1 HMCN2 PTPRD PTPRS PXDNL FGFR1 FGFR3 FGFR2 FGFR4 MERTK MYBPC2 | 2.75e-09 | 190 | 173 | 14 | PF07679 |
| Domain | IGc2 | PDGFRB FSTL4 MCAM IGSF22 CADM1 HMCN2 PTPRD PTPRS PXDNL FGFR1 FGFR3 FGFR2 FGFR4 IGSF1 MYBPC2 | 5.26e-09 | 235 | 173 | 15 | SM00408 |
| Domain | Ig_sub2 | PDGFRB FSTL4 MCAM IGSF22 CADM1 HMCN2 PTPRD PTPRS PXDNL FGFR1 FGFR3 FGFR2 FGFR4 IGSF1 MYBPC2 | 5.26e-09 | 235 | 173 | 15 | IPR003598 |
| Domain | FGF_rcpt_fam | 7.11e-09 | 4 | 173 | 4 | IPR016248 | |
| Domain | IG_LIKE | PDGFRB FSTL4 MCAM LEPR IGSF22 CADM1 HMCN2 PTPRD IGHD PTPRS PXDNL FGFR1 FGFR3 FGFR2 FGFR4 IGSF1 MERTK CD96 MYBPC2 | 1.56e-07 | 491 | 173 | 19 | PS50835 |
| Domain | Ig-like_fold | FNDC3B PDGFRB INSR FSTL4 MCAM FSD1 CAMTA2 LEPR IGSF22 CADM1 HMCN2 PTPRD IGHD PTPRS PXDNL FGFR1 FGFR3 FGFR2 FGFR4 IGSF1 MERTK CD96 MYBPC2 | 1.61e-07 | 706 | 173 | 23 | IPR013783 |
| Domain | Ig-like_dom | PDGFRB FSTL4 MCAM LEPR IGSF22 CADM1 HMCN2 PTPRD IGHD PTPRS PXDNL FGFR1 FGFR3 FGFR2 FGFR4 IGSF1 MERTK CD96 MYBPC2 | 2.27e-07 | 503 | 173 | 19 | IPR007110 |
| Domain | Pkinase_Tyr | PDGFRB INSR MAP3K20 TEC MAP3K12 FGFR1 FGFR3 FGFR2 FGFR4 MERTK | 3.41e-07 | 129 | 173 | 10 | PF07714 |
| Domain | IG | PDGFRB FSTL4 MCAM IGSF22 CADM1 HMCN2 PTPRD PTPRS PXDNL FGFR1 FGFR3 FGFR2 FGFR4 IGSF1 MERTK CD96 MYBPC2 | 4.05e-07 | 421 | 173 | 17 | SM00409 |
| Domain | Ig_sub | PDGFRB FSTL4 MCAM IGSF22 CADM1 HMCN2 PTPRD PTPRS PXDNL FGFR1 FGFR3 FGFR2 FGFR4 IGSF1 MERTK CD96 MYBPC2 | 4.05e-07 | 421 | 173 | 17 | IPR003599 |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | PDGFRB INSR MAP3K20 TEC MAP3K12 FGFR1 FGFR3 FGFR2 FGFR4 MERTK | 6.38e-07 | 138 | 173 | 10 | IPR001245 |
| Domain | Tyr_kinase_cat_dom | 1.58e-06 | 88 | 173 | 8 | IPR020635 | |
| Domain | TyrKc | 1.58e-06 | 88 | 173 | 8 | SM00219 | |
| Domain | ig | PDGFRB FSTL4 MCAM PTPRD IGHD PTPRS FGFR1 FGFR3 FGFR4 IGSF1 MERTK | 1.63e-06 | 190 | 173 | 11 | PF00047 |
| Domain | Immunoglobulin | PDGFRB FSTL4 MCAM PTPRD IGHD PTPRS FGFR1 FGFR3 FGFR4 IGSF1 MERTK | 1.63e-06 | 190 | 173 | 11 | IPR013151 |
| Domain | PROTEIN_KINASE_TYR | 3.30e-06 | 97 | 173 | 8 | PS00109 | |
| Domain | Tyr_kinase_AS | 3.30e-06 | 97 | 173 | 8 | IPR008266 | |
| Domain | - | FNDC3B PDGFRB INSR FSTL4 MCAM FSD1 LEPR IGSF22 CADM1 PTPRD PTPRS PXDNL FGFR1 FGFR3 FGFR2 FGFR4 IGSF1 MERTK CD96 MYBPC2 | 3.56e-06 | 663 | 173 | 20 | 2.60.40.10 |
| Domain | FN3 | 5.81e-05 | 185 | 173 | 9 | SM00060 | |
| Domain | PROTEIN_KINASE_ATP | PDGFRB INSR MAP3K20 TEC ERN2 MAP3K12 NEK9 SIK2 FGFR1 FGFR3 MAP3K15 FGFR2 FGFR4 MERTK | 9.87e-05 | 459 | 173 | 14 | PS00107 |
| Domain | FN3 | 1.02e-04 | 199 | 173 | 9 | PS50853 | |
| Domain | fn3 | 1.36e-04 | 162 | 173 | 8 | PF00041 | |
| Domain | FN3_dom | 1.47e-04 | 209 | 173 | 9 | IPR003961 | |
| Domain | Kinase-like_dom | PDGFRB INSR MAP3K20 ARHGAP35 TEC ERN2 MAP3K12 NEK9 SIK2 FGFR1 FGFR3 MAP3K15 FGFR2 FGFR4 MERTK | 1.63e-04 | 542 | 173 | 15 | IPR011009 |
| Domain | Prot_kinase_dom | PDGFRB INSR MAP3K20 TEC ERN2 MAP3K12 NEK9 SIK2 FGFR1 FGFR3 MAP3K15 FGFR2 FGFR4 MERTK | 1.91e-04 | 489 | 173 | 14 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | PDGFRB INSR MAP3K20 TEC ERN2 MAP3K12 NEK9 SIK2 FGFR1 FGFR3 MAP3K15 FGFR2 FGFR4 MERTK | 2.07e-04 | 493 | 173 | 14 | PS50011 |
| Domain | DAGKc | 2.64e-04 | 14 | 173 | 3 | SM00046 | |
| Domain | Diacylglycerol_kinase_cat_dom | 3.27e-04 | 15 | 173 | 3 | IPR001206 | |
| Domain | DAGK | 3.27e-04 | 15 | 173 | 3 | PS50146 | |
| Domain | DAGK_cat | 3.27e-04 | 15 | 173 | 3 | PF00781 | |
| Domain | NAD/diacylglycerol_kinase | 4.83e-04 | 17 | 173 | 3 | IPR016064 | |
| Domain | ArgoL1 | 1.25e-03 | 6 | 173 | 2 | PF08699 | |
| Domain | ArgoL1 | 1.25e-03 | 6 | 173 | 2 | IPR014811 | |
| Domain | JmjC | 1.37e-03 | 24 | 173 | 3 | PF02373 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_UBIQUITINATION_OF_RTK_BY_CBL | 9.20e-08 | 25 | 132 | 6 | M47934 | |
| Pathway | REACTOME_SIGNALING_BY_INSULIN_RECEPTOR | 1.18e-04 | 82 | 132 | 6 | M1021 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | 1.20e-04 | 118 | 132 | 7 | M713 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GF_RTK_PI3K_SIGNALING_PATHWAY | 1.26e-04 | 83 | 132 | 6 | M47961 | |
| Pathway | REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE | 1.46e-04 | 54 | 132 | 5 | M620 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY | 1.59e-04 | 55 | 132 | 5 | M47952 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_PI3K_SIGNALING_PATHWAY | 1.85e-04 | 89 | 132 | 6 | M47963 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FGF_FGFR_PI3K_SIGNALING_PATHWAY | 1.90e-04 | 31 | 132 | 4 | M47396 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_ERK_SIGNALING_PATHWAY | 2.22e-04 | 92 | 132 | 6 | M47927 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FGF_FGFR_RAS_ERK_SIGNALING_PATHWAY | 3.07e-04 | 35 | 132 | 4 | M47379 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 3.07e-04 | 35 | 132 | 4 | M47969 | |
| Pathway | WP_HIPPO_SIGNALING_REGULATION | 3.13e-04 | 98 | 132 | 6 | M39830 | |
| Pathway | WP_THERMOGENESIS | 5.27e-04 | 108 | 132 | 6 | M39746 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PNPLA2 SPHK2 CRYBG2 ZNF585A MYO7A UBE3B NAGLU MED14 KDM3B PFAS EXTL3 ARHGAP35 RALGAPA2 LYST GRAMD2A SH3TC1 PTPRS SPHK1 SORBS3 HELZ2 PYGB FGFR1 FGFR2 GCN1 HTT | 6.00e-10 | 1105 | 179 | 25 | 35748872 |
| Pubmed | 6.79e-10 | 4 | 179 | 4 | 9212826 | ||
| Pubmed | FGFR1-4 RNA-Based Gene Alteration and Expression Analysis in Squamous Non-Small Cell Lung Cancer. | 6.79e-10 | 4 | 179 | 4 | 36142417 | |
| Pubmed | 6.79e-10 | 4 | 179 | 4 | 11759058 | ||
| Pubmed | 6.79e-10 | 4 | 179 | 4 | 12644244 | ||
| Pubmed | 6.79e-10 | 4 | 179 | 4 | 9664689 | ||
| Pubmed | 6.79e-10 | 4 | 179 | 4 | 27154171 | ||
| Pubmed | Immunolocalization of fibroblast growth factor receptors in normal and wounded human skin. | 6.79e-10 | 4 | 179 | 4 | 12373339 | |
| Pubmed | The FGF system has a key role in regulating vascular integrity. | 6.79e-10 | 4 | 179 | 4 | 18776942 | |
| Pubmed | RNAi-based conditional gene knockdown in mice using a U6 promoter driven vector. | 6.79e-10 | 4 | 179 | 4 | 17304337 | |
| Pubmed | 8.43e-10 | 10 | 179 | 5 | 15470137 | ||
| Pubmed | 1.37e-09 | 40 | 179 | 7 | 30898150 | ||
| Pubmed | Conditional knockdown of Fgfr2 in mice using Cre-LoxP induced RNA interference. | 3.38e-09 | 5 | 179 | 4 | 15987787 | |
| Pubmed | The expression profiles of fibroblast growth factor 9 and its receptors in developing mice testes. | 3.38e-09 | 5 | 179 | 4 | 27078042 | |
| Pubmed | Different intracellular trafficking of FGF1 endocytosed by the four homologous FGF receptors. | 3.38e-09 | 5 | 179 | 4 | 16091423 | |
| Pubmed | FGF-dependent regulation of VEGF receptor 2 expression in mice. | 3.38e-09 | 5 | 179 | 4 | 21633168 | |
| Pubmed | 3.38e-09 | 5 | 179 | 4 | 27206683 | ||
| Pubmed | Expression of fibroblast growth factor receptors in peri-implantation mouse embryos. | 3.38e-09 | 5 | 179 | 4 | 9771645 | |
| Pubmed | 3.38e-09 | 5 | 179 | 4 | 28094278 | ||
| Pubmed | 3.38e-09 | 5 | 179 | 4 | 9013630 | ||
| Pubmed | The mouse Fgfrl1 gene coding for a novel FGF receptor-like protein. | 3.38e-09 | 5 | 179 | 4 | 11566361 | |
| Pubmed | 1.01e-08 | 6 | 179 | 4 | 10572038 | ||
| Pubmed | Evidence that the novel receptor FGFRL1 signals indirectly via FGFR1. | 1.01e-08 | 6 | 179 | 4 | 24026051 | |
| Pubmed | 1.01e-08 | 6 | 179 | 4 | 9010207 | ||
| Pubmed | 1.01e-08 | 6 | 179 | 4 | 16365308 | ||
| Pubmed | Regulation of fibroblast growth factor-23 signaling by klotho. | 1.01e-08 | 6 | 179 | 4 | 16436388 | |
| Pubmed | 1.01e-08 | 6 | 179 | 4 | 19232523 | ||
| Pubmed | 1.01e-08 | 6 | 179 | 4 | 29720668 | ||
| Pubmed | 1.19e-08 | 83 | 179 | 8 | 11114734 | ||
| Pubmed | Expression patterns of FGF receptors in the developing mammalian cochlea. | 2.35e-08 | 7 | 179 | 4 | 20131355 | |
| Pubmed | 2.35e-08 | 7 | 179 | 4 | 16772167 | ||
| Pubmed | 2.35e-08 | 7 | 179 | 4 | 8959336 | ||
| Pubmed | 4.67e-08 | 8 | 179 | 4 | 18187602 | ||
| Pubmed | 4.67e-08 | 8 | 179 | 4 | 17623664 | ||
| Pubmed | Syndecan-4 dependent FGF stimulation of mouse vibrissae growth. | 4.67e-08 | 8 | 179 | 4 | 16989989 | |
| Pubmed | Expression of Fgf receptors 1, 2, and 3 in the developing mid- and hindbrain of the mouse. | 8.38e-08 | 9 | 179 | 4 | 15830353 | |
| Pubmed | Dynamic activation of Wnt, Fgf, and Hh signaling during soft palate development. | 8.38e-08 | 9 | 179 | 4 | 31613912 | |
| Pubmed | Integration of FGF and TWIST in calvarial bone and suture development. | 8.38e-08 | 9 | 179 | 4 | 10751173 | |
| Pubmed | 8.38e-08 | 9 | 179 | 4 | 11335076 | ||
| Pubmed | 8.38e-08 | 9 | 179 | 4 | 15229180 | ||
| Pubmed | 1.07e-07 | 23 | 179 | 5 | 21223962 | ||
| Pubmed | 1.34e-07 | 3 | 179 | 3 | 31189094 | ||
| Pubmed | 1.34e-07 | 3 | 179 | 3 | 28056982 | ||
| Pubmed | 1.34e-07 | 3 | 179 | 3 | 8382556 | ||
| Pubmed | 1.34e-07 | 3 | 179 | 3 | 30755670 | ||
| Pubmed | 1.34e-07 | 3 | 179 | 3 | 25349422 | ||
| Pubmed | 1.34e-07 | 3 | 179 | 3 | 23185502 | ||
| Pubmed | 1.34e-07 | 3 | 179 | 3 | 19728793 | ||
| Pubmed | 1.34e-07 | 3 | 179 | 3 | 20301628 | ||
| Pubmed | 1.34e-07 | 3 | 179 | 3 | 21239433 | ||
| Pubmed | 1.34e-07 | 3 | 179 | 3 | 33433858 | ||
| Pubmed | 1.34e-07 | 3 | 179 | 3 | 9286594 | ||
| Pubmed | 1.34e-07 | 3 | 179 | 3 | 7896824 | ||
| Pubmed | 1.34e-07 | 3 | 179 | 3 | 29097598 | ||
| Pubmed | Enriched Environment Promotes Adult Hippocampal Neurogenesis through FGFRs. | 1.34e-07 | 3 | 179 | 3 | 33637561 | |
| Pubmed | Fibroblast growth factor receptor (FGFR) gene amplifications are rare events in bladder cancer. | 1.34e-07 | 3 | 179 | 3 | 24898159 | |
| Pubmed | 1.34e-07 | 3 | 179 | 3 | 18216705 | ||
| Pubmed | 1.34e-07 | 3 | 179 | 3 | 2165484 | ||
| Pubmed | 1.34e-07 | 3 | 179 | 3 | 31830366 | ||
| Pubmed | FGFR1/3 tyrosine kinase fusions define a unique molecular subtype of non-small cell lung cancer. | 1.34e-07 | 3 | 179 | 3 | 24850843 | |
| Pubmed | Regulation of external genitalia development by concerted actions of FGF ligands and FGF receptors. | 1.39e-07 | 10 | 179 | 4 | 15340846 | |
| Pubmed | Fgf20 is required for sensory epithelial specification in the developing cochlea. | 2.18e-07 | 11 | 179 | 4 | 18524904 | |
| Pubmed | 2.18e-07 | 11 | 179 | 4 | 8901049 | ||
| Pubmed | 2.18e-07 | 11 | 179 | 4 | 26906157 | ||
| Pubmed | The murine gene, Traube, is essential for the growth of preimplantation embryos. | 2.18e-07 | 11 | 179 | 4 | 11071758 | |
| Pubmed | Immunohistochemical study of genesis of the mouse oral vestibule. | 3.25e-07 | 12 | 179 | 4 | 14964469 | |
| Pubmed | 3.25e-07 | 12 | 179 | 4 | 10751172 | ||
| Pubmed | 3.25e-07 | 12 | 179 | 4 | 12460940 | ||
| Pubmed | The roles of FGF signaling in germ cell migration in the mouse. | 3.25e-07 | 12 | 179 | 4 | 16291796 | |
| Pubmed | Testis Determination Requires a Specific FGFR2 Isoform to Repress FOXL2. | 4.68e-07 | 13 | 179 | 4 | 28938467 | |
| Pubmed | 4.68e-07 | 13 | 179 | 4 | 9385055 | ||
| Pubmed | A point mutation in Fgf9 impedes joint interzone formation leading to multiple synostoses syndrome. | 4.68e-07 | 13 | 179 | 4 | 28169396 | |
| Pubmed | 4.68e-07 | 13 | 179 | 4 | 8883961 | ||
| Pubmed | Receptor specificity of the fibroblast growth factor family. | 4.68e-07 | 13 | 179 | 4 | 8663044 | |
| Pubmed | 5.34e-07 | 4 | 179 | 3 | 17414280 | ||
| Pubmed | Isolated sagittal and coronal craniosynostosis associated with TWIST box mutations. | 5.34e-07 | 4 | 179 | 3 | 17343269 | |
| Pubmed | 5.34e-07 | 4 | 179 | 3 | 10704861 | ||
| Pubmed | Astrocyte activation is suppressed in both normal and injured brain by FGF signaling. | 5.34e-07 | 4 | 179 | 3 | 25002516 | |
| Pubmed | 5.34e-07 | 4 | 179 | 3 | 32858001 | ||
| Pubmed | 5.34e-07 | 4 | 179 | 3 | 16210019 | ||
| Pubmed | Amplification of FRS2 and activation of FGFR/FRS2 signaling pathway in high-grade liposarcoma. | 5.34e-07 | 4 | 179 | 3 | 23393200 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | KDM3A RAD18 RPS3 MED14 KDM3B ARHGAP35 MORC2 GPRIN1 ZNF768 STRIP1 CBFA2T2 POP1 SORBS3 HELZ2 SMARCA2 ACIN1 SMARCC2 | 6.04e-07 | 774 | 179 | 17 | 15302935 |
| Pubmed | Class III myosins shape the auditory hair bundles by limiting microvilli and stereocilia growth. | 6.52e-07 | 14 | 179 | 4 | 26754646 | |
| Pubmed | FNDC3B SAMD1 METTL3 SENP3 MAP3K20 MED14 MORC2 ZNF768 CEP164 TUFM STRIP1 HMG20A JARID2 CRNKL1 PPP2R5E TBC1D10A MTHFD1 POP1 TNRC6A HELZ2 SMARCA2 TFB2M CTNND2 ALDH3A2 | 8.45e-07 | 1497 | 179 | 24 | 31527615 | |
| Pubmed | FGF8 is essential for formation of the ductal system in the male reproductive tract. | 8.86e-07 | 15 | 179 | 4 | 22110055 | |
| Pubmed | 8.86e-07 | 15 | 179 | 4 | 28465335 | ||
| Pubmed | 1.18e-06 | 16 | 179 | 4 | 24145799 | ||
| Pubmed | 1.18e-06 | 16 | 179 | 4 | 15201220 | ||
| Pubmed | 1.18e-06 | 16 | 179 | 4 | 24470103 | ||
| Pubmed | Fgfr1-dependent boundary cells between developing mid- and hindbrain. | 1.18e-06 | 16 | 179 | 4 | 15680361 | |
| Pubmed | 1.18e-06 | 16 | 179 | 4 | 11731698 | ||
| Pubmed | FGF21 signalling pathway and metabolic traits - genetic association analysis. | 1.33e-06 | 5 | 179 | 3 | 20717167 | |
| Pubmed | 1.33e-06 | 5 | 179 | 3 | 11714710 | ||
| Pubmed | 1.33e-06 | 5 | 179 | 3 | 19696444 | ||
| Pubmed | 1.33e-06 | 5 | 179 | 3 | 18315732 | ||
| Pubmed | Nectin-1 binds and signals through the fibroblast growth factor receptor. | 1.33e-06 | 5 | 179 | 3 | 22955284 | |
| Pubmed | Expression and biological activity of mouse fibroblast growth factor-9. | 1.33e-06 | 5 | 179 | 3 | 8576175 | |
| Pubmed | 1.33e-06 | 5 | 179 | 3 | 9300656 | ||
| Pubmed | SAMD1 INTU RAD18 ITCH GIGYF1 RALGAPA2 ZNF768 TUFM PHF21A CDKAL1 HMG20A ARHGEF33 PPP2R5E HMCN2 SH3TC1 TNRC6A SMARCA1 SMARCA2 SMARCC2 QSOX2 | 1.42e-06 | 1116 | 179 | 20 | 31753913 | |
| Pubmed | FGF8 Signaling Alters the Osteogenic Cell Fate in the Hard Palate. | 1.53e-06 | 17 | 179 | 4 | 29342370 | |
| Interaction | FGF6 interactions | 1.93e-07 | 7 | 176 | 4 | int:FGF6 | |
| Interaction | FGF18 interactions | 1.93e-07 | 7 | 176 | 4 | int:FGF18 | |
| Interaction | FGF5 interactions | 3.83e-07 | 8 | 176 | 4 | int:FGF5 | |
| Interaction | FGF23 interactions | 3.83e-07 | 8 | 176 | 4 | int:FGF23 | |
| Interaction | KLB interactions | 2.63e-06 | 12 | 176 | 4 | int:KLB | |
| Interaction | KL interactions | 5.26e-06 | 14 | 176 | 4 | int:KL | |
| Interaction | FGF7 interactions | 9.43e-06 | 16 | 176 | 4 | int:FGF7 | |
| Interaction | FGF9 interactions | 9.43e-06 | 16 | 176 | 4 | int:FGF9 | |
| Interaction | TOP3B interactions | PNPLA2 SPHK2 CRYBG2 ZNF585A MYO7A UBE3B NAGLU MED14 KDM3B PFAS EXTL3 ARHGAP35 RALGAPA2 LYST TUFM CDKAL1 GRAMD2A SH3TC1 PTPRS SPHK1 SORBS3 HELZ2 ACIN1 PYGB FGFR1 FGFR2 GCN1 SEC23B HTT SYNCRIP | 1.09e-05 | 1470 | 176 | 30 | int:TOP3B |
| Interaction | SNTB1 interactions | 1.83e-05 | 63 | 176 | 6 | int:SNTB1 | |
| Interaction | ST13P4 interactions | 1.97e-05 | 19 | 176 | 4 | int:ST13P4 | |
| Interaction | PTPN11 interactions | ITCH PDGFRB INSR FSD1 NEB LEPR MTHFD1 FGFR1 FGFR3 FGFR2 CDC73 FGFR4 SYNCRIP | 2.21e-05 | 368 | 176 | 13 | int:PTPN11 |
| Interaction | FRS2 interactions | 3.16e-05 | 102 | 176 | 7 | int:FRS2 | |
| Interaction | FGF1 interactions | 3.96e-05 | 44 | 176 | 5 | int:FGF1 | |
| Interaction | FGF17 interactions | 3.96e-05 | 44 | 176 | 5 | int:FGF17 | |
| Interaction | HSPA1B interactions | RAD18 PDGFRB INSR ST13 DENND6A FGFR1 FGFR3 FGFR2 FGFR4 MERTK MYBPC2 | 7.09e-05 | 301 | 176 | 11 | int:HSPA1B |
| Interaction | TMEM30B interactions | 1.01e-04 | 85 | 176 | 6 | int:TMEM30B | |
| Interaction | PLCG1 interactions | 1.13e-04 | 264 | 176 | 10 | int:PLCG1 | |
| Interaction | PTK7 interactions | 1.17e-04 | 168 | 176 | 8 | int:PTK7 | |
| Interaction | ITGB3 interactions | 1.27e-04 | 170 | 176 | 8 | int:ITGB3 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | PDGFRB FSTL4 IGSF22 HMCN2 PTPRD PTPRS PXDNL FGFR1 FGFR3 FGFR2 FGFR4 MERTK MYBPC2 | 8.80e-11 | 161 | 125 | 13 | 593 |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 9.83e-09 | 40 | 125 | 7 | 321 | |
| GeneFamily | Immunoglobulin like domain containing | 7.87e-06 | 193 | 125 | 9 | 594 | |
| GeneFamily | Fibronectin type III domain containing | 1.55e-05 | 160 | 125 | 8 | 555 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 5.87e-04 | 24 | 125 | 3 | 654 | |
| GeneFamily | Argonaute/PIWI family | 1.29e-03 | 8 | 125 | 2 | 408 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.68e-03 | 394 | 125 | 9 | 471 | |
| GeneFamily | Anoctamins | 2.06e-03 | 10 | 125 | 2 | 865 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | MYO7A ANO5 GRIK2 NLGN1 GIGYF1 ARHGAP35 NEB SEC31B CSMD3 DNAJC6 LYST ZFPM2 STRIP1 LMOD3 GDAP1L1 CADM1 RASA4 ANKAR TNRC6A CNTNAP4 ZFHX2 SMARCC2 CTNND2 | 1.71e-06 | 1106 | 177 | 23 | M39071 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.59e-07 | 184 | 177 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.59e-07 | 184 | 177 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.59e-07 | 184 | 177 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 7.91e-07 | 185 | 177 | 8 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.22e-06 | 196 | 177 | 8 | 54f4cf778f95a9ff662e5c7520916a25e605bf95 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.32e-06 | 198 | 177 | 8 | 328f1d5d8168e05edd301d3a0f2eb5c6cd1c67c8 | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.11e-06 | 163 | 177 | 7 | ed7319185c1ec384444309bb8be95691a0c2091c | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 4.11e-06 | 163 | 177 | 7 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.11e-06 | 163 | 177 | 7 | e6213900f56257fe38ac7852351bea0340294be0 | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.11e-06 | 163 | 177 | 7 | ef35d7ff09aa364734fea7fdaab6260c0a3fbf09 | |
| ToppCell | Tuft-tuft-1|World / Class top | 5.02e-06 | 168 | 177 | 7 | 8ddc2ec483ed2c6c0fb2ae521c6861ceb6d32e34 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.32e-06 | 174 | 177 | 7 | ccc79febfcf588d8294ffc712338be96de8a5033 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 6.56e-06 | 175 | 177 | 7 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 6.56e-06 | 175 | 177 | 7 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | T_cells-Tph_and_Tfh|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 6.81e-06 | 176 | 177 | 7 | 56c055488e34605d32562571a2fee621b47c9441 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.81e-06 | 176 | 177 | 7 | 77c3da2eaa072a6baefb5087fd07ec18c5e271cd | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-06 | 180 | 177 | 7 | 8bf6e8b6b45ce42f8c5f23e7cd1752ec8b3fa2d2 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.10e-06 | 184 | 177 | 7 | f4344f3c407b2d4d703fe56e43d84dbfe60ba833 | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 9.43e-06 | 185 | 177 | 7 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.43e-06 | 185 | 177 | 7 | 554c5d812197fbf66bf279fcc953277e926ade15 | |
| ToppCell | Monocytes-M2-like_CD16+_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 1.01e-05 | 187 | 177 | 7 | 59e31c51183ed4c9a3d0792c8005ea3a12b28dfa | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.01e-05 | 187 | 177 | 7 | a748b3a59e398e0da019db3f16d38adb1960c29f | |
| ToppCell | Adult-Epithelial-club_cell|Adult / Lineage, Cell type, age group and donor | 1.12e-05 | 190 | 177 | 7 | 756bff697d30aec56c0ebfca94295f084a15bf37 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.16e-05 | 191 | 177 | 7 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 1.16e-05 | 191 | 177 | 7 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.16e-05 | 191 | 177 | 7 | e7c605b56934d1383237c1f946dbccef25d91368 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-05 | 192 | 177 | 7 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.24e-05 | 193 | 177 | 7 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.33e-05 | 195 | 177 | 7 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.46e-05 | 198 | 177 | 7 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.46e-05 | 198 | 177 | 7 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.46e-05 | 198 | 177 | 7 | b58138581f1a9073267d64c1211c5b9b4de71d3e | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.46e-05 | 198 | 177 | 7 | 9d61483b0decac2fe90045b3474843360b2c49b3 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.51e-05 | 199 | 177 | 7 | 993fa050a095017135a6e723c77cd38b9d782e58 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.51e-05 | 199 | 177 | 7 | f835e7ffe976843b0edbf695762d463da85793f3 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-dn_T|COVID-19_Mild / Disease, condition lineage and cell class | 1.51e-05 | 199 | 177 | 7 | f307d4887b28cf60a591439e278fd668409cb104 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.56e-05 | 200 | 177 | 7 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.56e-05 | 200 | 177 | 7 | 7c2d499af60654b7b28f172ac2c914ad49fb74b4 | |
| ToppCell | Biopsy_IPF-Mesenchymal-Fibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 1.56e-05 | 200 | 177 | 7 | d8637f1e62d3fb9476dc51e1b1dc2f4b14b5fcd8 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 145 | 177 | 6 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | Mild/Remission-B_naive-5|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.83e-05 | 148 | 177 | 6 | 8b60f9843505660b3c9d5c7792976f902be4b94c | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_E|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.94e-05 | 149 | 177 | 6 | f18bddc84b064f3d57a1281d5172c404d87f25da | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-2|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.66e-05 | 155 | 177 | 6 | 0fd66c623cb433ceaa893bc21ba2e3b394faaf70 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 3.93e-05 | 157 | 177 | 6 | 7ceae5fe00c91d4feb8c314d3a31f027c03fa56f | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.69e-05 | 162 | 177 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 5.02e-05 | 164 | 177 | 6 | 519ab4fe885dfe4c50846f346a062acc2cb44299 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.37e-05 | 166 | 177 | 6 | 390cf5e56b72fcaf3b8520930bd35a3e3e173711 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.37e-05 | 166 | 177 | 6 | b1bebcbe17386cb102b11d551e62d46156ce0c68 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.37e-05 | 166 | 177 | 6 | 9a341dc7b756252caeaac1e934384911c880a634 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.55e-05 | 167 | 177 | 6 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.55e-05 | 167 | 177 | 6 | e44743b20a7435c579d8e999ddc4ca119d6753f2 | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.33e-05 | 171 | 177 | 6 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.33e-05 | 171 | 177 | 6 | 3d26ef58fe5231373d7df9ac79d225546918cf82 | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 6.97e-05 | 174 | 177 | 6 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.19e-05 | 175 | 177 | 6 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | P03-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.42e-05 | 176 | 177 | 6 | f3a54038cde58326f1caed96ecca33c141bcc8b3 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.90e-05 | 178 | 177 | 6 | 7467e5ab2fcb39cc4a2c7dd69722c91def3b6aea | |
| ToppCell | Adult-Epithelial-club_cell-D122|Adult / Lineage, Cell type, age group and donor | 7.90e-05 | 178 | 177 | 6 | 35a2e3ba98b6f857dbb79cf8ddb4846ddcda6c17 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.90e-05 | 178 | 177 | 6 | 30ca37f70d267cc9b40ca3e211f16d30360c3e6b | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.15e-05 | 179 | 177 | 6 | 7c8a2fa1326c73dc9e774df645b572864fd97133 | |
| ToppCell | facs-SCAT-Fat-3m-Lymphocytic-NK_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.15e-05 | 179 | 177 | 6 | 6f657c7a227f860934d0dfec9b97d35fd2cedfd2 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.15e-05 | 179 | 177 | 6 | b8ca29aebd25ebac441bebd769bbf98c536d3166 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 8.40e-05 | 180 | 177 | 6 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_FOS|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.66e-05 | 181 | 177 | 6 | 46c428037b6eac605635e20e8cc78bce744b4daa | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.93e-05 | 182 | 177 | 6 | be32b5b8153c1053cbb55f1fccfa27c3ee97c1e1 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.20e-05 | 183 | 177 | 6 | 2cf36ad89584eb9f8b04de52a1b511b7f3527884 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.20e-05 | 183 | 177 | 6 | 421265fa15d5a028cb567bb0904e670473ef102b | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.20e-05 | 183 | 177 | 6 | 8d45dff06a199b1369576657f7f9dc0249c5f841 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.20e-05 | 183 | 177 | 6 | 98fee6838acfaee5e2e449ba088764ec06b8bc57 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.48e-05 | 184 | 177 | 6 | da8d6e7944eb35e6cbea2feb7cbc2894787d723f | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 9.48e-05 | 184 | 177 | 6 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B-Branch_B3_(IPAN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.48e-05 | 184 | 177 | 6 | abb61e744a9031e0c91eb560a8f486a0ca5a01cc | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_FOS|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.48e-05 | 184 | 177 | 6 | 22c18964818fc9c8f18051f836d718937b0d8d12 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Hematologic-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.76e-05 | 185 | 177 | 6 | 969248b63d4ce335f223528de756bcddffadbd77 | |
| ToppCell | droplet-Spleen-nan-3m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 186 | 177 | 6 | 26f1e9930adf2fe4af0819e56f69915bd8330e4a | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.01e-04 | 186 | 177 | 6 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | P15-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.01e-04 | 186 | 177 | 6 | 521e6e007bbae73e7328153aa170cf04ca3c1093 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.01e-04 | 186 | 177 | 6 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Cbln1-Excitatory_Neuron.Slc17a7.Reln_(Medial_entorrhinal_cortexm,_Reln+/Cbln1+)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.01e-04 | 61 | 177 | 4 | 5e855b5462f42b7a1d0bbd518cc11072342ce0cc | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Cbln1-Excitatory_Neuron.Slc17a7.Reln_(Medial_entorrhinal_cortexm,_Reln+/Cbln1+)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.01e-04 | 61 | 177 | 4 | 2fc13475581431f82e0b5ef42e18cd29c9787666 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.04e-04 | 187 | 177 | 6 | dd1d91f101b837bba513f77defa6e6902b2c0570 | |
| ToppCell | P28-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.04e-04 | 187 | 177 | 6 | a4b41904ba05eb76212c949fc3ac197f906c8351 | |
| ToppCell | Adult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.04e-04 | 187 | 177 | 6 | ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.04e-04 | 187 | 177 | 6 | ae90c263f80c36a410150d499e268d198944a3d9 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 188 | 177 | 6 | cb9d0b48e2fd9cc576132803273b9c0382900944 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 188 | 177 | 6 | 8385fd384fc55e3b17802bb6698eb93b2c16d7f2 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 1.07e-04 | 188 | 177 | 6 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 188 | 177 | 6 | d1a4cd4db95d8d32b79156290f7867f32824cc87 | |
| ToppCell | LV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 1.10e-04 | 189 | 177 | 6 | 3922135d1f6fc768d71ba3b465585fead6ea68a8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 189 | 177 | 6 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 1.10e-04 | 189 | 177 | 6 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.10e-04 | 189 | 177 | 6 | d531399749409d614adca13d181830c6e3287508 | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.10e-04 | 189 | 177 | 6 | dc5164591dea45b420798b94dda211be03daa70c | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.13e-04 | 190 | 177 | 6 | 1196b8ea2c44c7c80f5ee589dd517e6a413f2077 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 190 | 177 | 6 | 1d8e169d2448a34180c415843bb49aa45ed540c5 | |
| ToppCell | Cerebellum-Macroglia-OLIGODENDROCYTE-O1-Trf|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.15e-04 | 63 | 177 | 4 | 83e1c91f830aadaf13e13254ce30189fd434bcc9 | |
| ToppCell | Cerebellum-Macroglia-OLIGODENDROCYTE-O1-Trf-Oligodendroyte.Trf.Il33_(Il33)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.15e-04 | 63 | 177 | 4 | f2532b1aa117eea550f0ae0b599780c4fe621407 | |
| ToppCell | Cerebellum-Macroglia-OLIGODENDROCYTE-O1-Trf-Oligodendroyte.Trf.Il33_(Il33)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.15e-04 | 63 | 177 | 4 | 71c3afda6534401320791b714e3e2fe83094c914 | |
| ToppCell | Cerebellum-Macroglia-OLIGODENDROCYTE-O1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.15e-04 | 63 | 177 | 4 | 0643435edf3280daf38c950e5bec287a9d5cb517 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.16e-04 | 191 | 177 | 6 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| Computational | Genes in the cancer module 85. | 7.28e-07 | 51 | 109 | 7 | MODULE_85 | |
| Computational | Genes in the cancer module 199. | 1.58e-06 | 57 | 109 | 7 | MODULE_199 | |
| Computational | RTK signaling. | 6.38e-06 | 46 | 109 | 6 | MODULE_259 | |
| Drug | 3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-(4-(4-ethylpiperazin-1-yl)-phenylamino)pyrimidin-4-yl)-1-methylurea | 3.45e-09 | 4 | 176 | 4 | ctd:C568950 | |
| Drug | Palifermin | 5.11e-08 | 6 | 176 | 4 | DB00039 | |
| Drug | PD 166285 | 1.63e-06 | 12 | 176 | 4 | CID005311382 | |
| Drug | Pilocarpine nitrate [148-72-1]; Up 200; 14.8uM; MCF7; HT_HG-U133A | ZNF573 UBE3B EXTL3 ERN2 LYST CEP164 SFXN3 SMARCC2 CTNND2 MERTK | 3.12e-06 | 196 | 176 | 10 | 5341_UP |
| Drug | 5H-benzo(4,5)cyclohepta(1,2-b)pyridin-5-one | 5.84e-06 | 16 | 176 | 4 | ctd:C561052 | |
| Drug | SC 19220; Down 200; 10uM; PC3; HT_HG-U133A | 1.93e-05 | 192 | 176 | 9 | 7065_DN | |
| Drug | Norethynodrel [68-23-5]; Down 200; 13.4uM; HL60; HT_HG-U133A | 2.01e-05 | 193 | 176 | 9 | 1860_DN | |
| Drug | Chloramphenicol [56-75-7]; Down 200; 12.4uM; PC3; HT_HG-U133A | 2.10e-05 | 194 | 176 | 9 | 5047_DN | |
| Drug | PNU-0230031 [267429-39-0]; Down 200; 10uM; PC3; HT_HG-U133A | 2.19e-05 | 195 | 176 | 9 | 3732_DN | |
| Drug | Quinidine hydrochloride monohydrate [6151-40-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 2.19e-05 | 195 | 176 | 9 | 3191_DN | |
| Drug | Heliotrine [303-33-3]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 2.28e-05 | 196 | 176 | 9 | 4739_DN | |
| Drug | Trimethoprim [738-70-5]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 2.37e-05 | 197 | 176 | 9 | 2307_DN | |
| Drug | Drofenine hydrochloride [548-66-3]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.37e-05 | 197 | 176 | 9 | 6776_DN | |
| Drug | beta- Belladonnine dichloroethylate [191355-47-2]; Up 200; 6uM; MCF7; HT_HG-U133A | 2.37e-05 | 197 | 176 | 9 | 2819_UP | |
| Drug | Isometheptene mucate; Down 200; 8.2uM; HL60; HT_HG-U133A | PNPLA2 TRAF1 ETV1 DGKG PGAP4 ARHGAP35 MAP3K12 KCNJ5 C1orf159 | 2.37e-05 | 197 | 176 | 9 | 3145_DN |
| Drug | Gemfibrozil [25812-30-0]; Down 200; 16uM; MCF7; HT_HG-U133A | 2.37e-05 | 197 | 176 | 9 | 2277_DN | |
| Drug | Minoxidil [38304-91-5]; Down 200; 19.2uM; MCF7; HT_HG-U133A | 2.47e-05 | 198 | 176 | 9 | 4800_DN | |
| Drug | Thonzonium bromide [553-08-2]; Down 200; 6.8uM; MCF7; HT_HG-U133A | 2.47e-05 | 198 | 176 | 9 | 5678_DN | |
| Drug | Molindone hydrochloride [15622-65-8]; Up 200; 12.8uM; HL60; HT_HG-U133A | 2.47e-05 | 198 | 176 | 9 | 2917_UP | |
| Drug | Dequalinium dichloride [522-51-0]; Up 200; 7.6uM; PC3; HT_HG-U133A | CRYBG2 ZNF573 PDGFRB CEP164 DENND3 KCNJ5 CBFA2T2 C8orf44 FGFR1 | 2.47e-05 | 198 | 176 | 9 | 6296_UP |
| Drug | Carbimazole [22232-54-8]; Up 200; 21.4uM; HL60; HT_HG-U133A | 2.47e-05 | 198 | 176 | 9 | 2437_UP | |
| Drug | Folic acid [59-30-3]; Down 200; 9uM; PC3; HT_HG-U133A | SENP3 CAMTA2 ERN2 MAP3K12 SORBS3 ACIN1 SMARCC2 C1orf159 FGFR2 | 2.57e-05 | 199 | 176 | 9 | 5844_DN |
| Drug | Repaglinide [135062-02-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 2.57e-05 | 199 | 176 | 9 | 3558_DN | |
| Drug | Lasalocid sodium salt [25999-20-6]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 2.57e-05 | 199 | 176 | 9 | 3360_DN | |
| Drug | Ribavirin [36791-04-5]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 2.67e-05 | 200 | 176 | 9 | 6521_DN | |
| Drug | Isoxicam [34552-84-6]; Down 200; 12uM; PC3; HT_HG-U133A | 2.67e-05 | 200 | 176 | 9 | 7268_DN | |
| Drug | p001 | 5.94e-05 | 2 | 176 | 2 | CID005320521 | |
| Drug | SU4984 | 5.94e-05 | 2 | 176 | 2 | DB02058 | |
| Drug | 3-(4-dimethylamino-benzylidenyl)-2-indolinone | 5.94e-05 | 2 | 176 | 2 | ctd:C117011 | |
| Drug | Oligosaccharides | 6.11e-05 | 28 | 176 | 4 | ctd:D009844 | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 6.48e-05 | 174 | 176 | 8 | 1019_UP | |
| Drug | Heparitin Sulfate | 7.05e-05 | 29 | 176 | 4 | ctd:D006497 | |
| Drug | Emetine dihydrochloride [316-42-7]; Down 200; 7.2uM; PC3; HT_HG-U133A | 9.22e-05 | 183 | 176 | 8 | 4243_DN | |
| Drug | Diflorasone Diacetate [33564-31-7]; Up 200; 8uM; HL60; HT_HG-U133A | 9.94e-05 | 185 | 176 | 8 | 2142_UP | |
| Drug | Alclometasone dipropionate [667634-13-2]; Up 200; 7.6uM; HL60; HT_HG-U133A | 9.94e-05 | 185 | 176 | 8 | 2532_UP | |
| Drug | LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A | 1.11e-04 | 188 | 176 | 8 | 5224_DN | |
| Drug | crisamicin A | 1.23e-04 | 13 | 176 | 3 | CID000125855 | |
| Drug | Furosemide [54-31-9]; Up 200; 12uM; PC3; HT_HG-U133A | 1.33e-04 | 193 | 176 | 8 | 4503_UP | |
| Drug | Nefopam hydrochloride [23327-57-3]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 1.43e-04 | 195 | 176 | 8 | 2317_DN | |
| Drug | Iressa; Down 200; 10uM; HL60; HG-U133A | 1.43e-04 | 195 | 176 | 8 | 541_DN | |
| Drug | (+) -Levobunolol hydrochloride [47141-41-3]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.43e-04 | 195 | 176 | 8 | 4980_DN | |
| Drug | Myosmine [532-12-7]; Down 200; 27.4uM; PC3; HT_HG-U133A | 1.43e-04 | 195 | 176 | 8 | 3737_DN | |
| Drug | Harmaline hydrochloride dihydrate [6027-98-1]; Up 200; 14uM; HL60; HT_HG-U133A | 1.43e-04 | 195 | 176 | 8 | 2149_UP | |
| Drug | Guanfacine hydrochloride [29110-48-3]; Down 200; 14.2uM; PC3; HT_HG-U133A | 1.43e-04 | 195 | 176 | 8 | 4660_DN | |
| Drug | Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 1.43e-04 | 195 | 176 | 8 | 2643_UP | |
| Drug | PD173074 | 1.48e-04 | 65 | 176 | 5 | CID000001401 | |
| Drug | Ioversol [87771-40-2]; Down 200; 5uM; MCF7; HT_HG-U133A | 1.48e-04 | 196 | 176 | 8 | 5326_DN | |
| Drug | Trimipramine maleate salt [521-78-8]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 1.48e-04 | 196 | 176 | 8 | 3342_DN | |
| Drug | Betaxolol hydrochloride [63659-19-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.48e-04 | 196 | 176 | 8 | 3208_DN | |
| Drug | Hexamethonium dibromide dihydrate [55-97-0]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.48e-04 | 196 | 176 | 8 | 4965_DN | |
| Drug | Ethisterone [434-03-7]; Down 200; 12.8uM; PC3; HT_HG-U133A | 1.48e-04 | 196 | 176 | 8 | 3783_DN | |
| Drug | Tetracycline hydrochloride [64-75-5]; Down 200; 8.4uM; PC3; HT_HG-U133A | 1.48e-04 | 196 | 176 | 8 | 5757_DN | |
| Drug | Norethynodrel [68-23-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 1.48e-04 | 196 | 176 | 8 | 1696_DN | |
| Drug | nitrobenzyl-DOTA | 1.50e-04 | 35 | 176 | 4 | CID000129949 | |
| Drug | Pirenperone [ 75444-65-4]; Up 200; 10.2uM; HL60; HT_HG-U133A | 1.53e-04 | 197 | 176 | 8 | 2455_UP | |
| Drug | Thioproperazine dimesylate [2347-80-0]; Up 200; 6.2uM; MCF7; HT_HG-U133A | 1.53e-04 | 197 | 176 | 8 | 6265_UP | |
| Drug | SC 19220; Down 200; 10uM; MCF7; HT_HG-U133A | 1.53e-04 | 197 | 176 | 8 | 7060_DN | |
| Drug | Proxyphylline [603-00-9]; Down 200; 16.8uM; MCF7; HT_HG-U133A | 1.53e-04 | 197 | 176 | 8 | 5993_DN | |
| Drug | Vinpocetine [42971-09-5]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.53e-04 | 197 | 176 | 8 | 3174_DN | |
| Drug | Methantheline bromide [53-46-3]; Up 200; 9.6uM; HL60; HT_HG-U133A | 1.53e-04 | 197 | 176 | 8 | 6137_UP | |
| Drug | Hydroflumethiazide [135-09-1]; Down 200; 12uM; MCF7; HT_HG-U133A | 1.53e-04 | 197 | 176 | 8 | 7019_DN | |
| Drug | PF-00562151-00 [351320-12-2]; Up 200; 10uM; PC3; HT_HG-U133A | 1.53e-04 | 197 | 176 | 8 | 6863_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.53e-04 | 197 | 176 | 8 | 6222_UP | |
| Drug | Ioversol [87771-40-2]; Up 200; 5uM; PC3; HT_HG-U133A | 1.53e-04 | 197 | 176 | 8 | 6726_UP | |
| Drug | Heparan Sulfate Proteoglycans | 1.55e-04 | 14 | 176 | 3 | ctd:D019812 | |
| Drug | PD 173074 | 1.55e-04 | 14 | 176 | 3 | ctd:C115711 | |
| Drug | 2,3-dichlorooctafluorobutane | 1.55e-04 | 14 | 176 | 3 | CID000078982 | |
| Drug | Tolbutamide [64-77-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 1.59e-04 | 198 | 176 | 8 | 2320_DN | |
| Drug | AH23848 hemicalcium salt hydrate; Down 200; 1uM; PC3; HT_HG-U133A | 1.59e-04 | 198 | 176 | 8 | 6885_DN | |
| Drug | Biperiden hydrochloride [1235-82-1]; Up 200; 11.4uM; HL60; HT_HG-U133A | 1.59e-04 | 198 | 176 | 8 | 2460_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; HL60; HT_HG-U133A | 1.59e-04 | 198 | 176 | 8 | 1163_UP | |
| Drug | Azacyclonol [115-46-8]; Up 200; 15uM; HL60; HG-U133A | 1.59e-04 | 198 | 176 | 8 | 2020_UP | |
| Drug | Quinidine hydrochloride monohydrate [6151-40-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 1.59e-04 | 198 | 176 | 8 | 6267_UP | |
| Drug | 1,1-dimethylbiguanide hydrochloride; Down 200; 10uM; MCF7; HG-U133A | 1.64e-04 | 199 | 176 | 8 | 61_DN | |
| Drug | Gentamicine sulfate [1405-41-0]; Down 200; 2.6uM; MCF7; HT_HG-U133A | 1.64e-04 | 199 | 176 | 8 | 7237_DN | |
| Drug | Orphenadrine hydrochloride [341-69-5]; Down 200; 13uM; PC3; HT_HG-U133A | 1.64e-04 | 199 | 176 | 8 | 4537_DN | |
| Drug | estradiol, USP; Up 200; 0.01uM; ssMCF7; HG-U133A | 1.64e-04 | 199 | 176 | 8 | 373_UP | |
| Drug | N-Acetyl-L-leucine [1188-21-2]; Up 200; 23uM; MCF7; HT_HG-U133A | 1.64e-04 | 199 | 176 | 8 | 6462_UP | |
| Drug | Sertaconazole nitrate [99592-39-9]; Down 200; 8uM; PC3; HT_HG-U133A | 1.70e-04 | 200 | 176 | 8 | 4475_DN | |
| Drug | indomethacin, USP; Up 200; 100uM; MCF7; HG-U133A | 1.70e-04 | 200 | 176 | 8 | 453_UP | |
| Drug | estrone benzoate | 1.77e-04 | 3 | 176 | 2 | ctd:C024552 | |
| Drug | ponatinib | 1.83e-04 | 68 | 176 | 5 | ctd:C545373 | |
| Drug | 1,2-dichlorohexafluorocyclobutane | 1.87e-04 | 37 | 176 | 4 | CID000009643 | |
| Drug | SU6668 | 2.10e-04 | 70 | 176 | 5 | CID000206042 | |
| Disease | bone disease (implicated_via_orthology) | 5.29e-09 | 5 | 170 | 4 | DOID:0080001 (implicated_via_orthology) | |
| Disease | TWIST1-related craniosynostosis | 7.48e-07 | 4 | 170 | 3 | cv:C4551902 | |
| Disease | Brachycephaly | 2.39e-06 | 17 | 170 | 4 | C0221356 | |
| Disease | high grade glioma (implicated_via_orthology) | 5.42e-06 | 44 | 170 | 5 | DOID:3070 (implicated_via_orthology) | |
| Disease | Craniosynostosis syndrome | 6.47e-06 | 7 | 170 | 3 | cv:C0010278 | |
| Disease | age at menarche | FNDC3B DNAH2 KDM3B DNAJC6 LEPR PHF21A CDKAL1 HMG20A CORO1A CADM1 PTPRD TNRC6A SMARCA2 IGSF1 | 9.69e-06 | 594 | 170 | 14 | EFO_0004703 |
| Disease | Head and Neck Carcinoma | 2.19e-05 | 10 | 170 | 3 | C3887461 | |
| Disease | JACKSON-WEISS SYNDROME | 3.30e-05 | 2 | 170 | 2 | C0795998 | |
| Disease | FGFR2-related craniosynostosis | 3.30e-05 | 2 | 170 | 2 | cv:CN231480 | |
| Disease | PFEIFFER SYNDROME | 3.30e-05 | 2 | 170 | 2 | 101600 | |
| Disease | Cutis Gyrata Syndrome of Beare And Stevenson | 3.30e-05 | 2 | 170 | 2 | C1852406 | |
| Disease | Pfeiffer type acrocephalosyndactyly | 3.30e-05 | 2 | 170 | 2 | C2931888 | |
| Disease | Isolated coronal synostosis | 3.30e-05 | 2 | 170 | 2 | cv:CN043619 | |
| Disease | short bowel syndrome (biomarker_via_orthology) | 3.30e-05 | 2 | 170 | 2 | DOID:10605 (biomarker_via_orthology) | |
| Disease | Jackson-Weiss syndrome | 3.30e-05 | 2 | 170 | 2 | cv:C0795998 | |
| Disease | Jackson-Weiss syndrome (is_implicated_in) | 3.30e-05 | 2 | 170 | 2 | DOID:0111337 (is_implicated_in) | |
| Disease | Pfeiffer syndrome | 3.30e-05 | 2 | 170 | 2 | cv:C0220658 | |
| Disease | JACKSON-WEISS SYNDROME | 3.30e-05 | 2 | 170 | 2 | 123150 | |
| Disease | Pfeiffer syndrome (is_implicated_in) | 3.30e-05 | 2 | 170 | 2 | DOID:14705 (is_implicated_in) | |
| Disease | Pfeiffer syndrome (implicated_via_orthology) | 3.30e-05 | 2 | 170 | 2 | DOID:14705 (implicated_via_orthology) | |
| Disease | Coffin-Siris syndrome | 5.15e-05 | 13 | 170 | 3 | C0265338 | |
| Disease | Intellectual Disability | PDGFRB NAGLU KDM3B PHF21A ACIN1 SMARCC2 FGFR2 TFB2M ALDH3A2 TET3 HTT | 6.10e-05 | 447 | 170 | 11 | C3714756 |
| Disease | Polydactyly | 6.17e-05 | 117 | 170 | 6 | C0152427 | |
| Disease | Lacrimoauriculodentodigital syndrome | 9.86e-05 | 3 | 170 | 2 | C0265269 | |
| Disease | Craniofacial dysostosis type 1 | 9.86e-05 | 3 | 170 | 2 | C2931196 | |
| Disease | Levy-Hollister syndrome | 9.86e-05 | 3 | 170 | 2 | cv:C0265269 | |
| Disease | acrocephalosyndactylia (is_implicated_in) | 9.86e-05 | 3 | 170 | 2 | DOID:12960 (is_implicated_in) | |
| Disease | Pfeiffer Syndrome | 9.86e-05 | 3 | 170 | 2 | C0220658 | |
| Disease | Saethre-Chotzen Syndrome | 9.86e-05 | 3 | 170 | 2 | C0175699 | |
| Disease | Congenital hypoplasia of radius | 9.86e-05 | 3 | 170 | 2 | C0685381 | |
| Disease | Synostotic Posterior Plagiocephaly | 9.96e-05 | 16 | 170 | 3 | C1833340 | |
| Disease | Craniosynostosis, Type 1 | 9.96e-05 | 16 | 170 | 3 | C4551902 | |
| Disease | Acrocephaly | 9.96e-05 | 16 | 170 | 3 | C0030044 | |
| Disease | Trigonocephaly | 9.96e-05 | 16 | 170 | 3 | C0265535 | |
| Disease | Scaphycephaly | 9.96e-05 | 16 | 170 | 3 | C0265534 | |
| Disease | Synostotic Anterior Plagiocephaly | 9.96e-05 | 16 | 170 | 3 | C2931150 | |
| Disease | Metopic synostosis | 9.96e-05 | 16 | 170 | 3 | C1860819 | |
| Disease | gout | 1.48e-04 | 196 | 170 | 7 | EFO_0004274 | |
| Disease | congenital diaphragmatic hernia (is_implicated_in) | 1.96e-04 | 4 | 170 | 2 | DOID:3827 (is_implicated_in) | |
| Disease | tyrosine-protein kinase TEC measurement | 1.96e-04 | 4 | 170 | 2 | EFO_0020830 | |
| Disease | Craniosynostosis | 1.99e-04 | 20 | 170 | 3 | C0010278 | |
| Disease | Congenital diaphragmatic hernia | 2.32e-04 | 21 | 170 | 3 | C0235833 | |
| Disease | aspartate aminotransferase measurement | MYO7A DNAH2 FSTL4 ETV1 PKD2L1 ANO5 ARHGAP35 LEPR CADM1 HMCN2 PTPRD SH3TC1 FGFR4 MERTK GCN1 | 2.48e-04 | 904 | 170 | 15 | EFO_0004736 |
| Disease | obesity (implicated_via_orthology) | 2.61e-04 | 215 | 170 | 7 | DOID:9970 (implicated_via_orthology) | |
| Disease | ceramide measurement | 4.45e-04 | 235 | 170 | 7 | EFO_0010222 | |
| Disease | cognitive disorder (implicated_via_orthology) | 4.88e-04 | 6 | 170 | 2 | DOID:1561 (implicated_via_orthology) | |
| Disease | rheumatoid arthritis (biomarker_via_orthology) | 4.88e-04 | 6 | 170 | 2 | DOID:7148 (biomarker_via_orthology) | |
| Disease | platelet-derived growth factor receptor beta measurement | 4.88e-04 | 6 | 170 | 2 | EFO_0008265 | |
| Disease | schizophrenia (implicated_via_orthology) | 6.50e-04 | 68 | 170 | 4 | DOID:5419 (implicated_via_orthology) | |
| Disease | protein S measurement | 6.80e-04 | 7 | 170 | 2 | EFO_0004637 | |
| Disease | hepatitis C virus infection, cirrhosis of liver | 6.80e-04 | 7 | 170 | 2 | EFO_0001422, EFO_0003047 | |
| Disease | Squamous cell carcinoma of lung | 8.24e-04 | 32 | 170 | 3 | C0149782 | |
| Disease | melanoma | 8.34e-04 | 126 | 170 | 5 | EFO_0000756 | |
| Disease | renal cell carcinoma (is_marker_for) | 8.95e-04 | 128 | 170 | 5 | DOID:4450 (is_marker_for) | |
| Disease | Head and Neck Neoplasms | 9.03e-04 | 33 | 170 | 3 | C0018671 | |
| Disease | prostate cancer (implicated_via_orthology) | 9.03e-04 | 33 | 170 | 3 | DOID:10283 (implicated_via_orthology) | |
| Disease | gestational diabetes (is_implicated_in) | 9.03e-04 | 8 | 170 | 2 | DOID:11714 (is_implicated_in) | |
| Disease | nemaline myopathy (implicated_via_orthology) | 9.03e-04 | 8 | 170 | 2 | DOID:3191 (implicated_via_orthology) | |
| Disease | Chromosomal Instability | 9.03e-04 | 8 | 170 | 2 | C1257806 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 9.03e-04 | 8 | 170 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | alcohol dependence, risky sexual behaviour measurement | 9.03e-04 | 8 | 170 | 2 | EFO_0007877, MONDO_0007079 | |
| Disease | neuritic plaque measurement | 9.86e-04 | 349 | 170 | 8 | EFO_0006798 | |
| Disease | Disproportionate short stature | 1.04e-03 | 77 | 170 | 4 | C0878659 | |
| Disease | uterine fibroid | 1.07e-03 | 199 | 170 | 6 | EFO_0000731 | |
| Disease | margarate 17:0 measurement | 1.16e-03 | 9 | 170 | 2 | EFO_0021066 | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 1.16e-03 | 9 | 170 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | Hamartoma Syndrome, Multiple | 1.16e-03 | 9 | 170 | 2 | C0018553 | |
| Disease | Giant Cell Glioblastoma | 1.43e-03 | 84 | 170 | 4 | C0334588 | |
| Disease | Cleft upper lip | 1.47e-03 | 39 | 170 | 3 | C0008924 | |
| Disease | Parkinson disease, disease progression measurement | 1.47e-03 | 39 | 170 | 3 | EFO_0008336, MONDO_0005180 | |
| Disease | Disorder of eye | 1.48e-03 | 212 | 170 | 6 | C0015397 | |
| Disease | serum alanine aminotransferase measurement | FNDC3B RAD18 ITCH PKD1L1 INSR MAP3K20 DNAH2 PKD2L1 ANO5 LEPR JARID2 MERTK HTT | 1.64e-03 | 869 | 170 | 13 | EFO_0004735 |
| Disease | C-reactive protein measurement | ZNF573 NUP210L NAGLU NLGN1 DNAJC6 ST13 LEPR TUFM PHF21A ZFPM2 KCNE4 SMARCC2 PYGB MERTK GCN1 PMF1 | 1.70e-03 | 1206 | 170 | 16 | EFO_0004458 |
| Disease | S-6-hydroxywarfarin to S-warfarin ratio measurement | 1.70e-03 | 88 | 170 | 4 | EFO_0803332 | |
| Disease | hippocampal CA4 volume | 1.71e-03 | 41 | 170 | 3 | EFO_0009396 | |
| Disease | Anorectal Malformations | 1.71e-03 | 41 | 170 | 3 | C3495676 | |
| Disease | gait measurement | 1.81e-03 | 150 | 170 | 5 | EFO_0007680 | |
| Disease | Cleft palate, isolated | 1.83e-03 | 42 | 170 | 3 | C1837218 | |
| Disease | Schizophrenia | PDGFRB GRIK2 NLGN1 CHRNA7 PRDX6 JARID2 SLC6A12 MTHFD1 SMARCA2 FGFR1 FGFR2 CTNND2 CHRFAM7A | 1.89e-03 | 883 | 170 | 13 | C0036341 |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.92e-03 | 152 | 170 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | FEV/FEC ratio | EFCAB5 JCAD FNDC3B ITCH MAP3K20 ETV1 DGKG NEB DENND3 CORO1A KANK1 CADM1 FGFR1 FGFR3 FGFR2 FGFR4 | 2.04e-03 | 1228 | 170 | 16 | EFO_0004713 |
| Disease | Malignant Head and Neck Neoplasm | 2.09e-03 | 44 | 170 | 3 | C0278996 | |
| Disease | congenital diaphragmatic hernia (implicated_via_orthology) | 2.10e-03 | 12 | 170 | 2 | DOID:3827 (implicated_via_orthology) | |
| Disease | craniosynostosis (is_implicated_in) | 2.10e-03 | 12 | 170 | 2 | DOID:2340 (is_implicated_in) | |
| Disease | chronic kidney disease (implicated_via_orthology) | 2.10e-03 | 12 | 170 | 2 | DOID:784 (implicated_via_orthology) | |
| Disease | nicotine dependence (implicated_via_orthology) | 2.10e-03 | 12 | 170 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | tetralogy of Fallot (is_implicated_in) | 2.47e-03 | 13 | 170 | 2 | DOID:6419 (is_implicated_in) | |
| Disease | hearing impairment | 2.52e-03 | 98 | 170 | 4 | C1384666 | |
| Disease | Diabetic Neuralgia | 2.87e-03 | 14 | 170 | 2 | C0751074 | |
| Disease | Diabetic Neuropathies | 2.87e-03 | 14 | 170 | 2 | C0011882 | |
| Disease | Asymmetric Diabetic Proximal Motor Neuropathy | 2.87e-03 | 14 | 170 | 2 | C0271674 | |
| Disease | Symmetric Diabetic Proximal Motor Neuropathy | 2.87e-03 | 14 | 170 | 2 | C0271673 | |
| Disease | Diabetic Mononeuropathy | 2.87e-03 | 14 | 170 | 2 | C0271678 | |
| Disease | Diabetic Autonomic Neuropathy | 2.87e-03 | 14 | 170 | 2 | C0271686 | |
| Disease | Diabetic Amyotrophy | 2.87e-03 | 14 | 170 | 2 | C0271685 | |
| Disease | Diabetic Polyneuropathies | 2.87e-03 | 14 | 170 | 2 | C0271680 | |
| Disease | lysophosphatidylcholine 16:1 measurement | 2.87e-03 | 14 | 170 | 2 | EFO_0010358 | |
| Disease | Diabetic Asymmetric Polyneuropathy | 2.87e-03 | 14 | 170 | 2 | C0393835 | |
| Disease | diet measurement | ITCH ZNF585A NUP210L KDM3B DGKG GRIK2 NLGN1 RALGAPA2 LEPR ZFPM2 TNRC6A SMARCA2 SIK2 CTNND2 | 3.12e-03 | 1049 | 170 | 14 | EFO_0008111 |
| Disease | cleft lip (is_implicated_in) | 3.30e-03 | 15 | 170 | 2 | DOID:9296 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KWVGKIPPDVLQDMA | 301 | O60507 | |
| PEEWGKLDPAQRDVM | 56 | Q9HBT8 | |
| EGRWRKLPKMPEAVG | 36 | Q9UKV3 | |
| PSLTEPVIRGLMKFW | 296 | Q16537 | |
| EKLREWPEPESVSLM | 16 | Q86W67 | |
| LMPVIPALWEAKAGR | 41 | Q96CB5 | |
| AWMIPDVPKDVVERI | 851 | Q75V66 | |
| VWDGPPENDMLLKEI | 1471 | Q7Z407 | |
| RVVDQPLKLMPQDWD | 426 | Q6P1J9 | |
| PLKLMPQDWDRVVAV | 431 | Q6P1J9 | |
| KIPPFISKGEIMNEW | 121 | Q8WWZ4 | |
| VIAPPERKISVWMGG | 326 | Q9BYD9 | |
| LPVKWMAPEALFDRV | 651 | P22455 | |
| DDLVPLALKVMPDSW | 381 | O95870 | |
| NLIGAMEEVPPDWER | 6201 | Q8WXG9 | |
| MQPGKPSDWELEGRK | 531 | A8MVX0 | |
| VLVESMIPRSTWKGP | 686 | O94983 | |
| RFIPLEWNPKGRIGM | 156 | Q9C0A0 | |
| MLENLPEWVTAKPVK | 71 | P51648 | |
| VMVWEIPDGGLMLPL | 106 | P31146 | |
| ADWIRISEMLLGPVP | 621 | Q96G46 | |
| WMIPDIPTDISDQIK | 926 | Q9NQ90 | |
| PEWEGAEQAPELMRL | 606 | A2RUS2 | |
| GWRDPELPEVIQMLQ | 546 | Q9UQB3 | |
| DPDGGKMPKWTRVIL | 321 | P36544 | |
| SLMAELGWRKDPVPD | 456 | P54802 | |
| LREWVESMGGKVPPA | 31 | Q8NFI4 | |
| LREWVESMGGKVPPA | 31 | P50502 | |
| KEAWMEPLQPTVRQG | 521 | O43374 | |
| ESRWPPGLAVMKTID | 6 | Q9NS91 | |
| GRPPVKKLLEMLQEW | 366 | Q6ZRP7 | |
| EPWFMRLNLGEEVPV | 86 | Q96MZ0 | |
| QDMEIGVTPWDPKKI | 11 | P48544 | |
| IPELPVWKTLVEMLQ | 696 | Q7Z5J8 | |
| TNGRLPVKWMAPEAL | 661 | P21802 | |
| LPDVPEDIRWMKEQT | 356 | Q96AD5 | |
| ATIKEIVVWPMLRPD | 411 | Q6PIW4 | |
| ERGQPIPEWKRQVMV | 441 | Q6ZVH7 | |
| DEERLWGEAMKPLPV | 126 | Q8WWG9 | |
| WGEAMKPLPVVSGLR | 131 | Q8WWG9 | |
| PPEGLDLVIQWCRML | 1001 | Q14667 | |
| LGEVIKMWGRVPFAP | 521 | O75420 | |
| WLRKELENAEFIPMP | 811 | Q8TD19 | |
| VDIRWMKPPTKQQDG | 401 | Q12866 | |
| FWKLGAPPREEMVDE | 631 | Q6PRD1 | |
| WELLGGPKPDSRMQE | 431 | Q0VAK6 | |
| PEITRMLGNEWSKLP | 131 | Q9NP66 | |
| PRLKEDQPWMVIEGI | 211 | Q9BTV5 | |
| CEARGVPLPLVSWMK | 3436 | Q8NDA2 | |
| KWTLRDDPVIEGPMY | 61 | Q76MJ5 | |
| KPVWEEELRMSGPAK | 166 | Q9P266 | |
| VPMVLTAGPKWLLDV | 146 | Q8WW38 | |
| GPIWDLRLMMDPLTG | 186 | O60506 | |
| ARQWKVGPEKRVPAM | 16 | O43439 | |
| WTGRGMEFKLIEPEE | 356 | P50549 | |
| LKIGRDWVPLSPGMK | 1326 | Q5H8C1 | |
| MLKKEEAIPWPGTLA | 536 | Q96BD5 | |
| IVEEGKVRKEPAWRP | 111 | Q6P1K2 | |
| GPELPMNWWIVKERV | 561 | Q14678 | |
| MVLKLKDWPPGEDFR | 1481 | Q7LBC6 | |
| IKVPMRGPEFWRIIN | 636 | P48357 | |
| LWPALLARMKIDPEA | 686 | Q92616 | |
| EACPVVPLWMRDKTL | 751 | P59047 | |
| LTWDMACRIILPPEK | 381 | P49411 | |
| GLLPVRWMAPESLKD | 1196 | P06213 | |
| NPEPMRILEWVGVGM | 256 | Q9BRR3 | |
| IIDGRLPEVMLPVWF | 121 | Q8N2Q7 | |
| MEPEEGTPLWRLQKL | 1 | Q9NX08 | |
| RKWILQDKPVFMEEP | 431 | Q2PPJ7 | |
| DPDGGKMPKWTRVIL | 231 | Q494W8 | |
| LGKFAVVMADPPWDI | 386 | Q86U44 | |
| VMGDDPDVPWRLLKL | 236 | O60244 | |
| WVEKGSEDVRLMKPP | 841 | Q9Y6X9 | |
| PPRIKDVMLADAQWE | 771 | Q13332 | |
| PGVRWLTLPLEIKME | 471 | Q9ULD6 | |
| ELFGPDRAIIPEMEW | 61 | A6NGQ2 | |
| PREMLGPVTFIWKSQ | 301 | Q99575 | |
| NEKPLPEGWEMRFTV | 476 | Q96J02 | |
| LWPALMVEDLIPGTR | 1196 | A1KZ92 | |
| GKPQPVMVTWVRVDD | 271 | Q9BY67 | |
| WDPTELRPILKEMLQ | 216 | P49619 | |
| EQFDEWILDPKGMIP | 291 | A4FU69 | |
| WILDPKGMIPKSVIQ | 296 | A4FU69 | |
| AISQPRLDMPEVLWK | 666 | Q9BZJ0 | |
| WPALGDRALVPMVEQ | 1126 | P42858 | |
| DPNVKMIWIKGTEPL | 261 | Q8N9C0 | |
| WSEPSEPLELVIKEM | 761 | Q8N6C5 | |
| VVRPWIKDRFMAPDI | 586 | P42357 | |
| MVLKLKDWPPGEDFR | 1041 | Q9Y4C1 | |
| LEPWDPGMRKLTVQT | 71 | Q53S99 | |
| RLPVKWMAPEALFDR | 661 | P11362 | |
| WKLVEVIPEGAMLRL | 276 | Q5VV42 | |
| EILWETVPSMKGDPV | 1071 | Q53EP0 | |
| LLWPDIGVPIMVVRT | 706 | O43909 | |
| LPCPEDVRNMVVLWI | 126 | Q8TAL5 | |
| GIPMPRITWLKNGVD | 366 | Q6MZW2 | |
| LPEGDMELRTPGTKW | 1041 | Q8N1P7 | |
| PPNILLMWLEDQREV | 301 | P01880 | |
| WKPVGMADLVTPEQV | 851 | O75061 | |
| IMPALEGKNIIIWLP | 11 | Q96C10 | |
| WELVLLGEPLVVMAP | 286 | Q8IWF6 | |
| QMEWLVLRDGVPPEA | 451 | Q99698 | |
| WMAPEVIRNEPVSEK | 276 | Q12852 | |
| TKPPFVMEKWIVGIA | 491 | Q9NYL2 | |
| LPVKWMAPEALFDRV | 656 | P22607 | |
| SIIEKWSMERLQAPP | 291 | Q13002 | |
| WDPRIMVPINGSVTK | 1211 | Q9BYK8 | |
| PAEPVRDVSWDEKGM | 906 | Q7Z2K8 | |
| EPESLEVLIPEMKWR | 196 | Q8IUY3 | |
| EVLIPEMKWRKVCPS | 201 | Q8IUY3 | |
| MLFPVPETWGLQERR | 286 | Q96HA4 | |
| DMFGSQPPLELIRLW | 2491 | Q9P225 | |
| GRKEKPSDPVEWTVM | 451 | Q6SPF0 | |
| GIWKFPIMLIATEPD | 3021 | Q6ZTR5 | |
| GRAEPVLMIDWPKAL | 1121 | Q8TDX9 | |
| MVKGEWIKPGAIVID | 221 | P11586 | |
| AVPESLPEKMRPVSW | 216 | Q5SR56 | |
| LPEKMRPVSWGAQIS | 221 | Q5SR56 | |
| PLEWNPSGKIGMRVE | 156 | Q8WYK1 | |
| KPGIEQGRLELWVDM | 1696 | Q9HC10 | |
| KEMVFEGGPRPWILE | 671 | Q5VU65 | |
| IMQKCWEEKFEIRPP | 936 | P09619 | |
| RGKFIKPWESPDEME | 1151 | P23468 | |
| WAAMDEIPVLRPSAK | 551 | Q92833 | |
| KVWLEVEPVGMLKEG | 251 | P43121 | |
| ALLRSKWGPMKEPTI | 736 | Q6ZN16 | |
| KMGGELWRVDIPLKL | 611 | Q96J94 | |
| AMAERKPQDVWVLLP | 16 | Q14D33 | |
| WFIPKGPNRGVIITM | 26 | O15342 | |
| MGELPLDINIQEPRW | 1 | Q9BWM7 | |
| KPRLMEEDELPSWII | 1271 | P51531 | |
| GMVEWIEPPKRERKA | 741 | P28370 | |
| WEAVNPELAPVMKTV | 61 | Q8NHS9 | |
| EVMLRCWQEKPEGRP | 596 | P42680 | |
| MSPPAWVELKDDRIE | 636 | Q8TC59 | |
| VEMGLPWGPALLIKR | 56 | Q8IVG5 | |
| WKDGDSVMVLPTIPE | 181 | P30041 | |
| EDMIGYRPWPLVKIS | 486 | P48065 | |
| GLPWAPKVREKDIEM | 421 | Q5VSL9 | |
| LEKVPWLSVMETPAR | 386 | Q8NDZ2 | |
| KEHKWMLIEVPVQRP | 266 | Q9H0K1 | |
| VLGIKVKIMLPWDPT | 181 | P23396 | |
| VPWTADIPLKVVGMF | 181 | Q9H5Q4 | |
| VMRPSVSWEKAGPEE | 36 | Q8TE82 | |
| RKVGEIKEGWIPMPV | 771 | Q6ZUB1 | |
| NMTPWEIPITKDIDG | 551 | Q9NQW1 | |
| MAPPVAERGLKSVVW | 1 | O00186 | |
| ITPGKPWEEARSFIM | 446 | Q9NRY4 | |
| KLVDPMDRKPTEIEW | 121 | Q96A35 | |
| VPGNLEEEEWVRPVM | 181 | Q8TAQ2 | |
| GMVVGDELKIPIRSW | 301 | Q15437 | |
| LGLPKEMTIWVDPFE | 86 | Q9NY30 | |
| IGIDPIKEPELMWLA | 36 | Q9UPV0 | |
| IKEPELMWLAREGIV | 41 | Q9UPV0 | |
| MEETWQSIKILPARP | 76 | Q7Z7G1 | |
| KLLENMPMPWEQIRD | 101 | Q6P2Q9 | |
| LEKGKAPWMVEPVRR | 66 | Q5HYK9 | |
| MEEDGLRWTPKSPLD | 221 | Q9H4L4 | |
| WMDVPGDKLLEPVVS | 396 | O75351 | |
| ALMDSLGPEWRLKLP | 131 | Q15785 | |
| REAMALAPWGPVKVK | 6 | P13682 | |
| RKLPWIMAKEEIRGP | 26 | Q5EBM4 | |
| VVVDLLERGKEPWMI | 76 | Q86YE8 | |
| AEREWERPPMAKEGN | 1406 | Q9C0A1 | |
| VVNKPKDGMSWPVIV | 511 | P40200 | |
| MWKLGRGRVLLDEPP | 1 | Q86YL5 | |
| EWRRLMGPTDPEEAK | 531 | Q8N427 | |
| GLLDRPDWEEAVKMP | 256 | Q9NRA0 | |
| QLPDGQRREWIKPIM | 411 | O15067 | |
| PFRKWEVGKDLPAML | 166 | Q3SY52 | |
| LPEALERWPVSMFEK | 381 | P11216 | |
| MEREALPWGLEPQDV | 1 | Q9H5H4 | |
| IVIMRGEYDALLPWP | 326 | Q13077 | |
| RKMPDLQLDWTFEEP | 156 | O60504 | |
| LWNPMKGEEGRIPAA | 1556 | O43151 | |
| KMLERKGWLAPSPGV | 736 | Q9P0L9 | |
| PEAEVVMLEQGKEPW | 71 | Q6P3V2 | |
| IWISENRKMVPVPEG | 16 | O15195 | |
| IIKPEWIRMFSTPEL | 906 | Q7Z3V4 | |
| LMERPDWETAIQKPL | 91 | Q9NYA1 | |
| SLAMIPKDWPLIIID | 111 | Q9WJR5 | |
| LDMSPGDPKWLDVIE | 141 | Q9BXI6 | |
| GWEEPSPESIRRKME | 986 | Q8NDV7 | |
| VWITILRFMGDLPEP | 1041 | Q13402 | |
| EKAGPPINVMVKEVW | 931 | Q14324 | |
| YVGVPTMRDDPKLVW | 4261 | P20929 |